• Morin: Mechanistic Assays and Workflow Guide

  2026-09-11

  Morin combines flavonoid bioactivity with fluorescent metal chelation, enabling linked workflows for oxidative stress, podocyte energy metabolism, neurobiology, and aluminum detection. This practical guide covers dosing, controls, assay design, and troubleshooting while separating evidence-supported mechanisms from exploratory recommendations.

• Gamithromycin PK/PD in Rabbit Pasteurellosis

  2026-09-11

  Wei et al. established a rabbit-specific pharmacokinetic/pharmacodynamic framework for gamithromycin against Pasteurella multocida, integrating plasma exposure, in vitro killing, post-antibiotic effects, and efficacy-linked AUC24h/MIC targets. The study supports subcutaneous gamithromycin as a candidate treatment strategy for rabbit pasteurellosis while illustrating how PK/PD thresholds can guide species- and pathogen-specific antimicrobial development.

• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow

  2026-09-10

  Use EZ Cap™ Human PTEN mRNA (ψUTP) to restore transient PTEN expression in mammalian models and interrogate PI3K/Akt-driven resistance. Its Cap1, pseudouridine-modified design supports a practical workflow spanning cell-based cancer research, pathway studies, and nanoparticle-enabled delivery experiments.

• BCA Protein Assay Kit: Principles and Workflow

  2026-09-10

  The BCA Protein Assay Kit provides bicinchoninic acid protein quantification through a copper-reduction reaction measured at 562 nm. Its stated 50–2000 μg/mL linear range, 0.5 μg minimum protein detection limit, and low sample requirement support reproducible protein concentration measurement in molecular biology workflows.

• S-Adenosylmethionine (SAM) Assay Workflows

  2026-09-09

  Build more interpretable methylation assays with Ademetionine by controlling concentration, matrix, storage, and reaction timing. This practical guide connects S-adenosylmethionine workflows to epigenetic, metabolic, and neurological research without confusing biochemical activity with clinical efficacy.

• Bay 11-7085: A Mechanistic Assay Compass

  2026-09-09

  Bay 11-7085 is an NF-κB activation inhibitor that connects inflammatory signaling with cell-cycle and apoptosis phenotypes. This guide uses recent ER stress–NF-κB research to show how to interpret the probe across disease-relevant assays without overclaiming pathway specificity.

• HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit

  2026-09-08

  This scenario-driven guide explains how HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit (SKU K1062) can support fluorescent RNA probe synthesis alongside cell viability, proliferation, and cytotoxicity workflows. It covers probe design, T7 transcription, Cy5-UTP optimization, interpretation, and practical product-selection criteria.

• Gramine and the CUL3–MTDH Ferroptosis Axis

  2026-09-07

  Gramine is emerging as a mechanistically informative ferroptosis inducer for triple-negative breast cancer research. This article interprets the CUL3–MTDH ubiquitination mechanism, translates the evidence into experimental planning, and defines the opportunities and limitations that matter for translational cancer biology programs.

• DHEA Workflows for PCOS and Neuroprotection

  2026-09-07

  Dehydroepiandrosterone (DHEA) can model inflammatory ovarian dysfunction while also serving as a neuroprotection agent in carefully controlled neural assays. This guide connects dose selection, conditioned-medium experiments, granulosa cell biology, and hippocampal neuron protection with practical troubleshooting.

• ECL Western Blotting Substrate: Workflow Guide

  2026-09-05

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for visualizing HRP-labeled proteins on immunoblots. It supports protein detection by chemiluminescence with X-ray film or CCD cameras, but it should not replace fluorescent or radioisotopic detection reagents.

• ATRX Loss Sensitizes Glioma Cells to PDGFR Inhibition

  2026-09-05

  The 2022 Cancers study identified ATRX deficiency as a potential biomarker of increased sensitivity to selected receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination experiments further suggest that ATRX status may help interpret RTK inhibitor trials and guide combinations with temozolomide.

• Phosbind Biotin for Phosphoprotein Detection

  2026-09-04

  Phosbind Biotin enables sequence-independent detection of phosphorylated proteins on PVDF membranes. This guide connects its dinuclear metal complex phosphate binding chemistry with practical protein phosphorylation analysis and the PtrbZIP12 drought-response study.

• Ibrexafungerp: Applied Antifungal Workflows

  2026-09-04

  Ibrexafungerp, also known as MK 3118, combines oral delivery with a distinct glucan synthase-binding profile that is useful for resistant Candida research. This guide converts supporting in vitro and murine evidence into practical susceptibility, acidic-pH, infection-model, and troubleshooting workflows.

• ARID1A-Dependent Resistance in Melanoma Multi-Omics

  2026-09-03

  The reference study integrates signaling, proteomic, and transcriptional evidence to define how ARID1A loss rewires early responses to BRAF/MAPK inhibition in melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a systems-level framework for studying persistent MAPK activity, immune-evasion features, and treatment adaptation.

• EZ Cap™ Human PTEN mRNA: Assay Design Guide

  2026-09-02

  EZ Cap™ Human PTEN mRNA (ψUTP) enables controlled, transient PTEN restoration for mechanistic cancer research. This guide focuses on assay architecture, delivery-aware controls, and how to interpret PI3K/Akt responses without confusing payload activity with nanoparticle performance.

8651 records 1/577 page Next 12345 下5页 Last page